Literature DB >> 15477422

Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient?

Giuseppe Boriani1, Barry J Maron, Win-Kuang Shen, Paolo Spirito.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15477422     DOI: 10.1161/01.CIR.0000144463.65977.C9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Device therapy: a subcutaneous ICD--preliminary results.

Authors:  Paolo Spirito; Giuseppe Boriani
Journal:  Nat Rev Cardiol       Date:  2010-10       Impact factor: 32.419

Review 2.  Management of hypertrophic cardiomyopathy.

Authors:  Paolo Spirito; Camillo Autore
Journal:  BMJ       Date:  2006-05-27

3.  Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giuseppe Boriani; Paolo Artale; Mauro Biffi; Cristian Martignani; Lorenzo Frabetti; Cinzia Valzania; Igor Diemberger; Matteo Ziacchi; Matteo Bertini; Claudio Rapezzi; Mario Parlapiano; Angelo Branzi
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

4.  Management of syncope in pediatric patients.

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

5.  Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  Camillo Autore; Giovanni Quarta; Paolo Spirito
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

6.  Role of implantable cardioverter defibrillators in the treatment of hypertrophic cardiomyopathy.

Authors:  Joydeep Ghosh; Johnson Francis; Barry J Maron
Journal:  Indian Pacing Electrophysiol J       Date:  2005-04-01

7.  The first cardioverter defibrillator implanted in Central Africa.

Authors:  Tantchou Tchoumi Jacques Cabral; Appolonia Budzee; Gianfranco Butera
Journal:  Pan Afr Med J       Date:  2016-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.